Protocol Search

Protocol No.

PSCI-23-130

Prinicipal Investigator

Komiya, Takefumi

Phase

Phase III

Age Group

Adult

Scope

National

Secondary Protocol No.

RMC-6236-301/V2.0

Title

RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 versus Docetaxel in Patients with Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC

Objective

Primary:
In the RAS (G12X-C) population, ie, RAS G12X
excluding G12C:
To compare the treatment effect of RMC-6236
versus docetaxel on
#8722; PFS (per Investigator)
#8722; OS

Secondary:
In the RAS (MUT) population:
To compare the treatment effect of RMC-6236
versus docetaxel on
#8722; PFS (per Investigator)
#8722; OS

Applicable Disease Sites

Lung

Status

Open

Participating Institutions

Hershey Medical Center